- Scheme Category:
- Equity Scheme >
- Sectoral/Thematic Funds
NAV: ₹ 9.9032 ↑ 0.52%
[as on 20 October, 2025]
NAV chart with SMA (Simple moving average) overlay
SMA (Simple Moving Average)
Returns
Name | YTD | 1D | 1W | 1M | 3M | 1Y | 3Y | 5Y | 7Y | 10Y |
---|
Baroda BNP Paribas Health and Wellness Fund Direct Growth | - | 0.52% | 1.28% | -0.47% | -1.74% | - | - | - | - | - |
Portfolio
Asset allocation
Equity | Debt | Realestate | Commodities | Cash & Equivalents |
---|
94.77% |
0.00% (Arbitrage: 0.00%) |
0.00% |
0.00% |
5.23% |
Equity
Name | Sector | Weight % |
---|
Sun Pharmaceutical Industries Limited | Pharmaceuticals & Biotechnology | 10.64% |
Divi's Laboratories Limited | Pharmaceuticals & Biotechnology | 7.64% |
Mankind Pharma Limited | Pharmaceuticals & Biotechnology | 7.53% |
Apollo Hospitals Enterprise Limited | Healthcare Services | 6.03% |
Cipla Limited | Pharmaceuticals & Biotechnology | 5.44% |
Max Healthcare Institute Limited | Healthcare Services | 5.44% |
Abbott India Limited | Pharmaceuticals & Biotechnology | 4.29% |
Aster DM Healthcare Limited | Healthcare Services | 4.08% |
Torrent Pharmaceuticals Limited | Pharmaceuticals & Biotechnology | 3.81% |
AstraZeneca Pharma India Limited | Pharmaceuticals & Biotechnology | 3.33% |
Gland Pharma Limited | Pharmaceuticals & Biotechnology | 2.92% |
Ajanta Pharma Limited | Pharmaceuticals & Biotechnology | 2.91% |
Cohance Lifesciences Limited | Pharmaceuticals & Biotechnology | 2.86% |
Biocon Limited | Pharmaceuticals & Biotechnology | 2.83% |
IPCA Laboratories Limited | Pharmaceuticals & Biotechnology | 2.82% |
ICICI Prudential Life Insurance Company Limited | Insurance | 2.81% |
JB Chemicals & Pharmaceuticals Limited | Pharmaceuticals & Biotechnology | 2.78% |
Natco Pharma Limited | Pharmaceuticals & Biotechnology | 2.59% |
Rainbow Childrens Medicare Limited | Healthcare Services | 2.43% |
Poly Medicure Limited | Healthcare Equipment & Supplies | 2.38% |
Dr. Reddy's Laboratories Limited | Pharmaceuticals & Biotechnology | 1.99% |
Lupin Limited | Pharmaceuticals & Biotechnology | 1.87% |
Fortis Healthcare Limited | Healthcare Services | 1.58% |
MedPlus Health Services Limited | Retailing | 1.42% |
Concord Biotech Limited | Pharmaceuticals & Biotechnology | 1.34% |
Dr. Lal Path Labs Limited | Healthcare Services | 1.01% |
Portfolio data is as on date 30 September, 2025
NAV (Net asset value) history
Baroda BNP Paribas Health and Wellness Fund Direct Growth - 30 days NAV history
Date | NAV |
---|
20 October, 2025 | 9.9032 |
17 October, 2025 | 9.8521 |
16 October, 2025 | 9.7941 |
15 October, 2025 | 9.7475 |
14 October, 2025 | 9.7344 |
13 October, 2025 | 9.7784 |
10 October, 2025 | 9.7923 |
9 October, 2025 | 9.7118 |
8 October, 2025 | 9.6631 |
7 October, 2025 | 9.6658 |
6 October, 2025 | 9.6335 |
3 October, 2025 | 9.5538 |
1 October, 2025 | 9.5502 |
30 September, 2025 | 9.4969 |
29 September, 2025 | 9.4830 |
26 September, 2025 | 9.5118 |
25 September, 2025 | 9.6800 |
24 September, 2025 | 9.7174 |
23 September, 2025 | 9.7843 |
22 September, 2025 | 9.8450 |
19 September, 2025 | 9.9504 |
18 September, 2025 | 9.9018 |
17 September, 2025 | 9.8127 |
16 September, 2025 | 9.8215 |
15 September, 2025 | 9.8143 |
12 September, 2025 | 9.8681 |
11 September, 2025 | 9.8501 |
10 September, 2025 | 9.8423 |
9 September, 2025 | 9.8073 |
8 September, 2025 | 9.7797 |
FAQ (Frequently asked questions)
What is latest/current NAV/price of Baroda BNP Paribas Health and Wellness Fund Direct Growth?
The latest NAV of Baroda BNP Paribas Health and Wellness Fund Direct Growth is 9.9032 as on 20 October, 2025.